|Videos|May 25, 2023
Efficacy of Immunotherapies for dMMR or MMRp Advanced/Recurrent Endometrial Cancer
The panel discusses their opinions on the use of immunotherapy in different populations of women with advanced/recurrent endometrial cancer.
Advertisement
Episodes in this series
Advertisement
Related to this article
Beth Erickson, MD, FACR, FASTRO, FABS, discussed pioneering MRI-guided brachytherapy at MCW and her priorities as incoming ASTRO president-elect.
The European Medicines Agency’s CHMP recommended approval of relacorilant plus nab-paclitaxel for platinum-resistant ovarian cancer based on the ROSELLA trial.
Advertisement
Advertisement
Trending on CancerNetwork
1
Lutetium Lu 177 Dotatate Biosimilar Earns Final FDA Approval in GEP-NETs
2
Neoantigen Vaccine Shows Encouraging Activity in Head and Neck Cancer
3
CELMoDs After T-Cell–Engaging Therapy in Multiple Myeloma
4
Using Intrathecal Dendritic Cells for Leptomeningeal Disease From Breast Cancer
5